title: The neodymium:YAG laser and the resectoscope for the treatment of menorrhagia.
abstract: OBJECTIVE
  To assess the efficacy of destruction of the endometrium by ablation with a neodymium:YAG laser or resection with electrocautery in the management of menorrhagia.
  
  
  METHODS
  The efficacy of the treatment was assessed subjectively by each patient comparing the duration and amount of her menstrual bleeding before and after the operative procedure. Randomisation of treatments or patients was not undertaken.
  
  
  METHODS
  The study was carried out in tertiary centres. Most of the procedures were undertaken in the Day Surgery Units of those centres.
  
  
  METHODS
  A total of 64 patients underwent one or more procedures. One had continuous bleeding per vagina on hormone replacement therapy, all others had menorrhagia which they considered incapacitating.
  
  
  METHODS
  Of the patients 40 had removal of endometrium via a resectoscope and 24 had endometrial vaporisation with the neodymium:YAG laser.
  
  
  METHODS
  The outcome was assessed by each patient as amenorrhoea, hypomenorrhoea, attainment of normal menstrual amount or no change in menstrual loss.
  
  
  RESULTS
  Both operative procedures were satisfactory in that amenorrhoea, hypomenorrhoea or normal menstruation was achieved in 87% of cases. Uterine perforation occurred on two occasions with thermal bowel injury in one patient.
  
  
  CONCLUSIONS
  Destruction of the endometrium by the neodymium:YAG laser or the resectoscope is a successful way of managing menorrhagia in the absence of demonstrable pathological cause in nearly 90% of cases. The performance of the procedures as day cases with minimal discomfort makes them attractive alternatives to hysterectomy in the management of menorrhagia.
authors.affiliation: Department of Obstetrics and Gynaecology, University of Adelaide, Queen Victoria Hospital, Rose Park, SA.
authors.forename: O M
authors.initials: OM
authors.lastname: Petrucco
authors.forename: A
authors.initials: A
authors.lastname: Gillespie
mesh_terms: D003613:Danazol / Q000008:administration & dosage; D004564:Electrocoagulation / Q000295:instrumentation*; D004717:Endometrium / Q000601:surgery*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D015907:Hysteroscopy; D053685:Laser Therapy; D008595:Menorrhagia / Q000503:physiopathology / Q000601:surgery*; D008598:Menstruation; D011183:Postoperative Complications; D012008:Recurrence
chemical_list: D003613:Danazol